| Category： | Drug Impurities and Intermediates | |
|---|---|---|
| Appearance： | powder | |
| Purity： | 95~98%(HPLC) | |
| Storage conditions： | -20°C under seal save, placed in ventilated, dry environment | |
| Application： | All our products are for research and lab only. Injecting, eating and other ways are forbidden. | |
| Package： | 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized | |
| SMILES： | O=C([C@H](CC(C)C)NC([C@H](CC1=CNC2=CC=CC=C12)NC([C@H](C)NC([C@H]([C@@H](C)CC)NC([C@H](CC1C=CC=CC=1)NC([C@H](CCC(=O)O)NC([C@H](CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](C(=O)O)NC(CCCCCCCCCCCCCCCCC(=O)O)=O)=O)=O)=O)NC([C@H](C)NC([C@H](C)NC([C@H](CCC(N)=O)NC(CNC([C@H](CCC(=O)O)NC([C@H](CC(C)C)NC([C@H](CC1C=CC(=CC=1)O)NC([C@H](CO)NC([C@H](CO)NC([C@H](C(C)C)NC([C@H](CC(=O)O)NC([C@H](CO)NC([C@H]([C@@H](C)O)NC([C@H](CC1C=CC=CC=1)NC([C@H]([C@@H](C)O)NC(CNC([C@H](CCC(=O)O)NC(C(C)(C)NC([C@H](CC1=CN=CN1)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(=O)O)=O)CCCNC(=N)N)=O)=O)CCCNC(=N)N)=O)C(C)C |
| DL0001 | Oxaliplatin | CAS No.61825-94-3 | C8H14N2O4PT |
| TBW02522 | Repaglinide | CAS No.135062-02-1 | C27H36N2O4 |
| TBW02523 | Dapagliflozin propanediol monohydrate | CAS No.960404-48-2 | C24H35CLO9 |
| TBW02524 | Vildagliptin | CAS No.274901-16-5 | C17H25N3O2 |
| TBW02525 | Sermaglutide | CAS No.910463-68-2 | C187H291N45O59 |
| TBW03198 | Posaconazole | CAS No.171228-49-2 | C37H42F2N8O4 |
| TBW03702 | 2-Fluoro-4-(pyridin-2-YL)benzaldehyde | CAS No.893637-84-8 | C12H8FNO |
| TBW04080 | Tadalafil EP Impurity D | CAS No.951661-81-7 | C22H20CLN3O4 |
